Cargando…
Comparative Effectiveness Of Fluoroquinolone Antibiotic Use In Uncomplicated Acute Exacerbations Of COPD: A Multi-Cohort Study
PURPOSE: Fluoroquinolone antibiotics are associated with rare, but severe adverse events. They are frequently used for the treatment of acute exacerbations of COPD (AECOPD). While their effectiveness in severe exacerbations requiring hospitalisation has been well documented, the potential benefit in...
Autores principales: | , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6927224/ https://www.ncbi.nlm.nih.gov/pubmed/31908442 http://dx.doi.org/10.2147/COPD.S226324 |
_version_ | 1783482265770131456 |
---|---|
author | Ernst, Pierre Dahl, Matthew Chateau, Dan Daneman, Nick Quail, Jacqueline Sketris, Ingrid S Fisher, Anat Zhang, Jianguo Bugden, Shawn |
author_facet | Ernst, Pierre Dahl, Matthew Chateau, Dan Daneman, Nick Quail, Jacqueline Sketris, Ingrid S Fisher, Anat Zhang, Jianguo Bugden, Shawn |
author_sort | Ernst, Pierre |
collection | PubMed |
description | PURPOSE: Fluoroquinolone antibiotics are associated with rare, but severe adverse events. They are frequently used for the treatment of acute exacerbations of COPD (AECOPD). While their effectiveness in severe exacerbations requiring hospitalisation has been well documented, the potential benefit in the ambulatory setting is less clear, especially in uncomplicated patients with COPD. PATIENTS AND CHARACTERISTICS: We carried out a retrospective cohort study using health care databases from six Canadian provinces in subjects visiting their physician for uncomplicated COPD. Subjects dispensed either a quinolone or other antibiotics were compared using inverse probability of treatment weights with high dimensional propensity scores on 30-day outcomes, including repeat visits, hospitalisation for AECOPD and subsequent antibiotic prescription. Results from each province were combined by random effects meta-analysis. RESULTS: We identified 286,866 AECOPD events among 203,642 unique individuals. The frequency of fluoroquinolone use, mostly levofloxacin and moxifloxacin, varied by province and ranged from 8% to 32% of AECOPD antibiotic prescriptions. The risk of a repeat ambulatory care visit was increased among patients who were dispensed a fluoroquinolone compared with other antibiotics (OR 1.32, 95% CI 1.27–1.36). The risk of a hospitalisation for AECOPD was also higher with fluoroquinolones (OR 1.52, 95% CI 1.33–1.74). There was no difference in subsequent antibiotic prescriptions (OR 1.00, 95% CI 0.94–1.07). CONCLUSION: There is no apparent benefit in short-term outcomes with fluoroquinolones as compared to other antibiotics for the ambulatory treatment of AECOPD in uncomplicated patients. These findings support current recommendations that fluoroquinolones be reserved for AECOPD in patients with recurrent exacerbations, significant co-morbidity or requiring hospitalisation. |
format | Online Article Text |
id | pubmed-6927224 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2019 |
publisher | Dove |
record_format | MEDLINE/PubMed |
spelling | pubmed-69272242020-01-06 Comparative Effectiveness Of Fluoroquinolone Antibiotic Use In Uncomplicated Acute Exacerbations Of COPD: A Multi-Cohort Study Ernst, Pierre Dahl, Matthew Chateau, Dan Daneman, Nick Quail, Jacqueline Sketris, Ingrid S Fisher, Anat Zhang, Jianguo Bugden, Shawn Int J Chron Obstruct Pulmon Dis Original Research PURPOSE: Fluoroquinolone antibiotics are associated with rare, but severe adverse events. They are frequently used for the treatment of acute exacerbations of COPD (AECOPD). While their effectiveness in severe exacerbations requiring hospitalisation has been well documented, the potential benefit in the ambulatory setting is less clear, especially in uncomplicated patients with COPD. PATIENTS AND CHARACTERISTICS: We carried out a retrospective cohort study using health care databases from six Canadian provinces in subjects visiting their physician for uncomplicated COPD. Subjects dispensed either a quinolone or other antibiotics were compared using inverse probability of treatment weights with high dimensional propensity scores on 30-day outcomes, including repeat visits, hospitalisation for AECOPD and subsequent antibiotic prescription. Results from each province were combined by random effects meta-analysis. RESULTS: We identified 286,866 AECOPD events among 203,642 unique individuals. The frequency of fluoroquinolone use, mostly levofloxacin and moxifloxacin, varied by province and ranged from 8% to 32% of AECOPD antibiotic prescriptions. The risk of a repeat ambulatory care visit was increased among patients who were dispensed a fluoroquinolone compared with other antibiotics (OR 1.32, 95% CI 1.27–1.36). The risk of a hospitalisation for AECOPD was also higher with fluoroquinolones (OR 1.52, 95% CI 1.33–1.74). There was no difference in subsequent antibiotic prescriptions (OR 1.00, 95% CI 0.94–1.07). CONCLUSION: There is no apparent benefit in short-term outcomes with fluoroquinolones as compared to other antibiotics for the ambulatory treatment of AECOPD in uncomplicated patients. These findings support current recommendations that fluoroquinolones be reserved for AECOPD in patients with recurrent exacerbations, significant co-morbidity or requiring hospitalisation. Dove 2019-12-18 /pmc/articles/PMC6927224/ /pubmed/31908442 http://dx.doi.org/10.2147/COPD.S226324 Text en © 2019 Ernst et al. http://creativecommons.org/licenses/by-nc/3.0/ This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/). By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms (https://www.dovepress.com/terms.php). |
spellingShingle | Original Research Ernst, Pierre Dahl, Matthew Chateau, Dan Daneman, Nick Quail, Jacqueline Sketris, Ingrid S Fisher, Anat Zhang, Jianguo Bugden, Shawn Comparative Effectiveness Of Fluoroquinolone Antibiotic Use In Uncomplicated Acute Exacerbations Of COPD: A Multi-Cohort Study |
title | Comparative Effectiveness Of Fluoroquinolone Antibiotic Use In Uncomplicated Acute Exacerbations Of COPD: A Multi-Cohort Study |
title_full | Comparative Effectiveness Of Fluoroquinolone Antibiotic Use In Uncomplicated Acute Exacerbations Of COPD: A Multi-Cohort Study |
title_fullStr | Comparative Effectiveness Of Fluoroquinolone Antibiotic Use In Uncomplicated Acute Exacerbations Of COPD: A Multi-Cohort Study |
title_full_unstemmed | Comparative Effectiveness Of Fluoroquinolone Antibiotic Use In Uncomplicated Acute Exacerbations Of COPD: A Multi-Cohort Study |
title_short | Comparative Effectiveness Of Fluoroquinolone Antibiotic Use In Uncomplicated Acute Exacerbations Of COPD: A Multi-Cohort Study |
title_sort | comparative effectiveness of fluoroquinolone antibiotic use in uncomplicated acute exacerbations of copd: a multi-cohort study |
topic | Original Research |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6927224/ https://www.ncbi.nlm.nih.gov/pubmed/31908442 http://dx.doi.org/10.2147/COPD.S226324 |
work_keys_str_mv | AT ernstpierre comparativeeffectivenessoffluoroquinoloneantibioticuseinuncomplicatedacuteexacerbationsofcopdamulticohortstudy AT dahlmatthew comparativeeffectivenessoffluoroquinoloneantibioticuseinuncomplicatedacuteexacerbationsofcopdamulticohortstudy AT chateaudan comparativeeffectivenessoffluoroquinoloneantibioticuseinuncomplicatedacuteexacerbationsofcopdamulticohortstudy AT danemannick comparativeeffectivenessoffluoroquinoloneantibioticuseinuncomplicatedacuteexacerbationsofcopdamulticohortstudy AT quailjacqueline comparativeeffectivenessoffluoroquinoloneantibioticuseinuncomplicatedacuteexacerbationsofcopdamulticohortstudy AT sketrisingrids comparativeeffectivenessoffluoroquinoloneantibioticuseinuncomplicatedacuteexacerbationsofcopdamulticohortstudy AT fisheranat comparativeeffectivenessoffluoroquinoloneantibioticuseinuncomplicatedacuteexacerbationsofcopdamulticohortstudy AT zhangjianguo comparativeeffectivenessoffluoroquinoloneantibioticuseinuncomplicatedacuteexacerbationsofcopdamulticohortstudy AT bugdenshawn comparativeeffectivenessoffluoroquinoloneantibioticuseinuncomplicatedacuteexacerbationsofcopdamulticohortstudy AT comparativeeffectivenessoffluoroquinoloneantibioticuseinuncomplicatedacuteexacerbationsofcopdamulticohortstudy |